Philips parent Royal Philips has secured clearance from the U.S. Food and Drug Administration (FDA) for its Zenition 30 mobile C-arm.
Zenition 30 offers greater control over C-arm positioning during surgical procedures, with pushbuttons on the flat detector that allow clinicians to unlock and adjust the arm’s horizontal, orbital, and rotational positioning, the company said. It also features Philips’ MetalSmart software, which automatically adjusts image contrast and brightness to improve image quality and eliminate blooming while maintaining a low radiation dose, according to the firm.